ifocustest.com

What It Is

iFocus Health is a digital health tool designed to measure the effectiveness of ADHD treatment. Its core idea is to let patients read naturally on a computer, use the built-in camera to capture eye position and eye-movement data, and then generate an iFocus score and a comprehensive report through proprietary AI algorithms. The results are intended for discussion among patients, parents, and clinicians when evaluating treatment outcomes. The website also states that iFocus technology has been acquired by HarmonEyes, and that the current iFocus platform will no longer be available after September 1, 2025; future versions will be developed by HarmonEyes.

Core Capabilities and Workflow

The product emphasizes that it requires “no additional equipment”—only a desktop or laptop computer with a camera. A typical workflow is: the patient completes a session during a reading task, while the system captures eye movements in real time; the AI processes the data and generates a score and full report; the user then downloads or emails the report and shares it with a doctor. Reports can also incorporate the medication name, dosage, dosing time, and self-reported side-effect information such as sleep, mood, and appetite. The official recommendation is to complete a session 1–3 hours after taking medication, to better align with the medication’s peak effect. Two completed sessions can produce an initial score; additional sessions can improve accuracy, and five sessions can generate a more advanced score.

Pricing, Privacy, and Integrations

The crawled text does not disclose pricing, free trials, insurance coverage, or payment methods, nor does it state whether the product has any medical-device regulatory clearance. On privacy, the company says it uses encryption in transit, secure storage, and strict access controls, and complies with applicable privacy regulations. During reading sessions, it records only eye position and eye-movement data, without saving video or audio. In terms of integrations, the only visible options are report download, email delivery, and manual sharing with doctors; no API, EHR, or clinic-system integrations are disclosed.

Pros, Cons, and Best-Fit Users

Its strengths are a low barrier to use and no need for a dedicated eye tracker, making it suitable for families and clinical settings that want a relatively low-disruption way to track ADHD medication effects. The AI also turns complex eye-movement data into scores and reports that are easier to discuss. The limitations are also clear: the platform’s lifecycle is uncertain; it only supports desktop or laptop computers, with mobile support not yet available; data quality may be affected by lighting, camera placement, whether the reading task is completed properly, and similar factors; and there is limited information on pricing, validation evidence, and real-world clinical implementation.

Access from China and Alternatives

The website does not provide information on access from China, a Chinese-language interface, RMB payments, or local compliance, so its practical availability is unknown. For users in China looking for alternatives, a more realistic approach would be to consult local psychiatry or pediatric developmental-behavioral clinics, combining scale-based assessments, physician follow-up, and compliant digital therapeutics or attention-training tools, rather than relying directly on this platform.